TABLE VIII.
Adjusted hazard ratios for the prediction of event-free survival from anxiety and medication adherence controlling for age, gender, medication use, left ventricular ejection fraction, and New York Heart Association classification
Hazard Ratio |
95% Confidence Interval |
P Value |
|
---|---|---|---|
Age | 1.007 | .982–1.032 | .60 |
Gender | .902 | .487–1.670 | .74 |
Prescribed angiotensin-converting enzyme inhibitor | .538 | .293–.988 | .05 |
Prescribed beta-adrenergic blocker | .442 | .181–1.078 | .07 |
Left ventricular ejection fraction | .988 | .966–1.010 | .29 |
New York Heart Association classification | 1.141 | .632–2.050 | .66 |
Second anxiety quartile* | .884 | .336–2.321 | .80 |
Third anxiety quartile* | .952 | .413–2.194 | .91 |
Fourth anxiety quartile* | 1.682 | .795–3.560 | .17 |
Medication adherence | 1.345 | 1.060–1.708 | .02 |
Compared to lowest quartile of anxiety
Omnibus test of model coefficients χ2 = 29.73, P = .001